title: [Medullary cancer of the thyroid].
abstract: Although rare (10% of thyroid cancers), medullary thyroid cancer is remarkable by the presence of a specific biological marker; elevation of blood calcitonin. It allows its preoperative diagnosis and this extensive surgery which is the only efficient treatment. The possibility of hereditary form (30%) must always be kept in mind; they can now be detected by genetic screening since specific mutations on Ret gene have been recently discovered. Follow up and early treatment of at risk subjects in a family is therefore possible and permits definitive surgical cure.
authors.affiliation: Service d'endocrinologie, Hôpital Avicenne, Bobigny.
authors.forename: E
authors.initials: E
authors.lastname: Modigliani
mesh_terms: D018276:Carcinoma, Medullary / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics / Q000628:therapy; D006801:Humans; D011379:Prognosis; D012307:Risk Factors; D013964:Thyroid Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics / Q000628:therapy
vernacular_title: Le cancer médullaire de la thyroïde.